Evidence map›Paper›PMID 42618356›Full record

ArticleJournal of dermatological science2026

CXCL14 is a novel biomarker for mast cell infiltration in the melanoma tumor microenvironment.

Sanjay Lietzau, Mitchell C Cutler, Mengyan Li, Miroslav Hejna, Jenny Chung, Naotomo Kambe, Jun S Song, Akinori Kawakami, Kenji Kabashima

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of dermatological science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sanjay LietzauDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mitchell C CutlerDepartment of Physics, University of Illinois Urbana-Champaign, Champaign, IL, USA.
Mengyan LiDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Miroslav HejnaDepartment of Physics, University of Illinois Urbana-Champaign, Champaign, IL, USA; Institute for Genomic Biology, University of Illinois Urbana-Champaign, Champaign, IL, USA.
Jenny ChungCity University of New York School of Medicine, New York, NY, USA.
Naotomo KambeDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Jun S SongDepartment of Physics, University of Illinois Urbana-Champaign, Champaign, IL, USA; Institute for Genomic Biology, University of Illinois Urbana-Champaign, Champaign, IL, USA; Cancer Center at Illinois, University of Illinois Urbana-Champaign, Champaign, IL, USA.
Akinori KawakamiDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: kawakamia@kuhp.kyoto-u.ac.jp.
Kenji KabashimaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; A(⁎)STAR Skin Research Labs (A(⁎)SRL), Singapore Immunology Network (SIgN), and Skin Research Institute of Singapore (SRIS), Agency for Science Technology and Research (A(⁎)STAR), Singapore. Electronic address: kaba@kuhp.kyoto-u.ac.jp.

Funding

Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing DataR01CA163336 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Jun S Song · 2012 to 2026
$4.4M
NCI NIH HHS R01 CA163336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42618356
PMCPMC13573672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.